<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The role of platelet-derived growth factor (PDGF) remains unknown in <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined the effects of PDGF receptor (PDGFR) inactivation on <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in the endovascular <z:mpath ids='MPATH_81'>perforation</z:mpath> model of SAH in rats </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Rats were assigned to sham, SAH plus vehicle, and SAH plus <z:chebi fb="0" ids="31690">imatinib mesylate</z:chebi> (<z:chebi fb="0" ids="45783">imatinib</z:chebi>) groups (n = 4 per group) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="45783">Imatinib</z:chebi> (50 mg/kg body weight), an inhibitor of the tyrosine kinases of PDGFR, or vehicle was administered intraperitoneally 30 min post-SAH </plain></SENT>
<SENT sid="4" pm="."><plain>Vasospasm was evaluated in the left (<z:mpath ids='MPATH_81'>perforation</z:mpath>-sided) internal carotid artery by means of neurobehavioral tests, India ink angiography, and immunohistochemistry at 24 h after SAH </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:chebi fb="0" ids="45783">Imatinib</z:chebi> significantly inhibited post-SAH PDGFR activation in the left internal carotid artery, in which vasospasm was significantly prevented </plain></SENT>
<SENT sid="6" pm="."><plain>Animal's neurobehavior also showed a tendency to improve by <z:chebi fb="0" ids="45783">imatinib</z:chebi> treatment </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: PDGF may play an important role in the pathogenesis of vasospasm after SAH </plain></SENT>
</text></document>